Tuesday, August 4, 2026

Tailored Chemotherapy Boosts Survival Rates for Elderly Colon Cancer Patients

A study reveals tailored treatment for elderly colon cancer patients boosts survival rates, challenging age-based treatment limitations.

GC Biopharma’s Varicella Vaccine “VARICELLAJU” Wins Approval in Guatemala

GC Biopharma's varicella vaccine VARICELLAJU gains marketing approval in Guatemala, marking its Latin American debut and ensuring safety.

North Korea “This Year Is Completion Year”… Nation Wide Hospital·Factory Construction Performance Display[Daily North Korea]

North Korea celebrates achievements in local development and construction under Kim Jong Un, marking a year of historic milestones.

Tag: SillaJen

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

Revolutionary Cancer Treatment SJ-650: What Makes It a Game Changer in Oncology?

SillaJen's SJ-650 cancer treatment platform gains recognition with publication in Molecular Therapy, showcasing its innovative approach and efficacy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.